hydrochlorothiazide has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pease, DR | 1 |
| Martinez-Escala, ME | 1 |
| Jimenez, J | 1 |
| Guitart, J | 1 |
| West, DP | 1 |
| Nardone, B | 1 |
1 other study available for hydrochlorothiazide and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Cutaneous T-cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program.
Topics: Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Ly | 2021 |